55th Annual Meeting (October 28-November 2, 2008): Efficacy and Safety of Aripiprazole in the Treatment of Serious Behavioral Problems Associated with Autistic Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial

Thursday, October 30, 2008: 11:30 AM

River Exhibition Hall (Sheraton Chicago Hotel & Towers)

Randall Owen, M.D.,

Robert L. Findling, M.D., University Hospitals Case Medical Center, Cleveland, OH

Gabrielle A. Carlson, M.D., SUNY at Stony Brook, Stony Brook, NY

Margaretta Nyilas, M.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ

Taro Iwamoto, Ph.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ

Raymond Mankoski, M.D., Ph.D., Bristol-Myers Squibb, Plainsboro, NJ

Sheila Assunção-Talbott, M.D., Ph.D., Bristol-Myers Squibb, Plainsboro, NJ

William Carson, M.D., Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ

Dan A. Oren, M.D., Bristol-Myers Squibb, Woodbridge, CT

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 3.60 Efficacy and Safety of Aripiprazole in the Treatment of Serious Behavioral Problems Associated with Autistic Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial